Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.55x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.55Latest market snapshot
Implied fair value · at BUD's multiple
$30.1230.8% below market
12.37 SUPN revenue / share×2.43x BUD P/S=$30.12
Market $43.55Implied $30.12
BUD · current priceP/S 2.43x
$80.37Latest market snapshot
Implied fair value · at SUPN's multiple
$116.2244.6% above market
33.01 BUD revenue / share×3.52x SUPN P/S=$116.22
Market $80.37Implied $116.22